melanoma (skin)
Showing NaN - NaN of 25
Melanoma (Skin) Trial in Los Angeles (CP-675,206)
Completed
- Melanoma (Skin)
- CP-675,206
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center at UCLA
Oct 1, 2020
Melanoma (Skin) Trial in Los Angeles (maximum tolerated dose of anti-cytotoxic T-lymphocyte-associated antigen-4 mAb)
Completed
- Melanoma (Skin)
- maximum tolerated dose of anti-cytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center at UCLA
Jul 30, 2020
Melanoma (Skin) Trial in Los Angeles (dendritic cell-MART-1 peptide vaccine)
Completed
- Melanoma (Skin)
- dendritic cell-MART-1 peptide vaccine
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center at UCLA
Jul 30, 2020
Melanoma (Skin), Neuroblastoma, Sarcoma Trial in Australia, Canada, United States (hu14.18-IL2 fusion protein)
Completed
- Melanoma (Skin)
- +3 more
- hu14.18-IL2 fusion protein
-
Little Rock, Arkansas
- +58 more
Aug 6, 2014
Intraocular Melanoma, Melanoma (Skin) Trial in Los Angeles (MART-1 antigen, gp100 antigen, incomplete Freund's adjuvant)
Terminated
- Intraocular Melanoma
- Melanoma (Skin)
- MART-1 antigen
- +4 more
-
Los Angeles, California
- +1 more
May 20, 2014
Melanoma (Skin) Trial in Los Angeles, Ann Arbor (gp100 antigen, incomplete Freund's adjuvant, sargramostim)
Completed
- Melanoma (Skin)
- gp100 antigen
- +3 more
-
Los Angeles, California
- +1 more
May 20, 2014
Intraocular Melanoma, Melanoma (Skin) Trial in Duarte, Los Angeles (gp100 antigen, incomplete Freund's adjuvant, recombinant
Completed
- Intraocular Melanoma
- Melanoma (Skin)
- gp100 antigen
- +3 more
-
Duarte, California
- +1 more
May 20, 2014
Melanoma (Skin) Trial in Los Angeles (MART-1 antigen, aldesleukin, gp100 antigen)
Terminated
- Melanoma (Skin)
- MART-1 antigen
- +10 more
-
Los Angeles, CaliforniaUSC/Norris Comprehensive Cancer Center and Hospital
May 20, 2014
Intraocular Melanoma, Melanoma (Skin) Trial in Los Angeles (biological, drug, procedure)
Completed
- Intraocular Melanoma
- Melanoma (Skin)
- MART-1 antigen
- +7 more
-
Los Angeles, CaliforniaUSC/Norris Comprehensive Cancer Center and Hospital
May 20, 2014
Intraocular Melanoma, Melanoma (Skin) Trial in Los Angeles (MART-1 antigen, gp100 antigen, incomplete Freund's adjuvant)
Completed
- Intraocular Melanoma
- Melanoma (Skin)
- MART-1 antigen
- +5 more
-
Los Angeles, CaliforniaUSC/Norris Comprehensive Cancer Center and Hospital
May 20, 2014
Intraocular Melanoma, Melanoma (Skin) Trial in Los Angeles, Ann Arbor (MART-1 antigen, gp100:209-217(210M) peptide vaccine,
Completed
- Intraocular Melanoma
- Melanoma (Skin)
- MART-1 antigen
- +3 more
-
Los Angeles, California
- +1 more
May 19, 2014
Melanoma (Skin) Trial in Los Angeles (oblimersen sodium, dacarbazine)
Unknown status
- Melanoma (Skin)
- oblimersen sodium
- dacarbazine
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center, UCLA
Jan 3, 2014
Melanoma (Skin) Trial in Los Angeles (paclitaxel albumin-stabilized nanoparticle formulation)
Completed
- Melanoma (Skin)
- paclitaxel albumin-stabilized nanoparticle formulation
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center at UCLA
Dec 18, 2013
Melanoma (Skin) Trial in Los Angeles (autologous dendritic cell-allogeneic melanoma tumor cell lysate vaccine)
Completed
- Melanoma (Skin)
- autologous dendritic cell-allogeneic melanoma tumor cell lysate vaccine
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center at UCLA
Nov 5, 2013
Melanoma (Skin) Trial in United States (recombinant interferon alfa, thalidomide)
Completed
- Melanoma (Skin)
- recombinant interferon alfa
- thalidomide
-
Mobile, Alabama
- +93 more
Jun 20, 2013
Melanoma (Skin) Trial in United States (D1/3-MAGE-3-His fusion protein, SB-AS02B adjuvant)
Completed
- Melanoma (Skin)
- D1/3-MAGE-3-His fusion protein
- SB-AS02B adjuvant
-
Tucson, Arizona
- +6 more
Jun 21, 2013
Melanoma (Skin), Metastatic Cancer Trial in United States (stereotactic radiosurgery)
Terminated
- Melanoma (Skin)
- Metastatic Cancer
- stereotactic radiosurgery
-
Mobile, Alabama
- +85 more
Jan 30, 2013
Melanoma (Skin) Trial in Los Angeles (Synchrotope TA2M)
Completed
- Melanoma (Skin)
- Synchrotope TA2M
-
Los Angeles, CaliforniaUSC/Norris Comprehensive Cancer Center and Hospital
Jul 9, 2012
Melanoma (Skin) Trial in United States (MKC1106-MT)
Completed
- Melanoma (Skin)
- MKC1106-MT
-
Tucson, Arizona
- +4 more
May 11, 2011
Melanoma (Skin) Trial in United States (aldesleukin, filgrastim, recombinant interferon alfa)
Completed
- Melanoma (Skin)
- aldesleukin
- +5 more
-
Mobile, Alabama
- +93 more
Jan 28, 2010